欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
CY/H/0110/002
药品名称
Lapozan 5 mg Filmtabletten
活性成分
olanzapine 5.0 mg
剂型
Film-coated tablet
上市许可持有人
Medochemie Ltd. P.O.Box 51409 3505 Limassol Cyprus
参考成员国 - 产品名称
Cyprus (CY)
互认成员国 - 产品名称
Greece (GR)
Latvia (LV)
Lapozan 5 mg apvalkotās tabletes
Lithuania (LT)
Lapozan 5 mg plėvele dengtos tabletės
Bulgaria (BG)
Lapozan
Romania (RO)
Lapozan 5 mg comprimate filmate
Slovakia (SK)
Lapozan 5mg
许可日期
2009/08/31
最近更新日期
2024/01/02
药物ATC编码
N05AH03 olanzapine
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final SPC
|
DE1852_Lapozan_spc-oro-clean_20140924_renewal
Date of last change:2015/04/28
Final SPC
|
DE1852_Lapozan_spc-tabs-clean_20140924_renewal
Date of last change:2015/04/28
Final PL
|
DE1852_Lapozan_pil-oro-clean_20140924_renewal
Date of last change:2015/04/28
Final PL
|
DE1852_Lapozan_pil-tabs-clean_20140924_renewal
Date of last change:2015/04/28
Final Labelling
|
DE1852_Lapozan_labelling-oro-clean_20140924_renewal
Date of last change:2015/04/28
Final Labelling
|
DE1852_Lapozan_labelling-tabs-clean_20140924_renewal
Date of last change:2015/04/28
PAR
|
PAREN-DE1852-Olanzapin-20100310-final
Date of last change:2013/06/10
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase